Stock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion

Stock Track03-10

CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.

The sharp rise follows the company's release of strong annual results, which showed revenue jumping 218.7% year-on-year to RMB 126 million, primarily driven by its CT053 autologous BCMA CAR-T cell therapy. The company also reported a significant 87.7% narrowing of its net loss to RMB 97.861 million.

Additionally, CARSGEN-B was officially included in the Hong Kong Stock Connect scheme, which is expected to provide mainland investors with more convenient access to the stock. Market analysts view this inclusion as recognition of the company's core CAR-T business development potential and operational compliance, which should enhance market attention and liquidity for the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106814148?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 10:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106814148","market":"nz","top_or_hot":-1,"title":"Stock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion","media":"Stock Track","content":"<p>CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.</p><p>The sharp rise follows the company's release of strong annual results, which showed revenue jumping 218.7% year-on-year to RMB 126 million, primarily driven by its CT053 autologous BCMA CAR-T cell therapy. The company also reported a significant 87.7% narrowing of its net loss to RMB 97.861 million.</p><p>Additionally, CARSGEN-B was officially included in the Hong Kong Stock Connect scheme, which is expected to provide mainland investors with more convenient access to the stock. Market analysts view this inclusion as recognition of the company's core CAR-T business development potential and operational compliance, which should enhance market attention and liquidity for the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-10 10:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.</p><p>The sharp rise follows the company's release of strong annual results, which showed revenue jumping 218.7% year-on-year to RMB 126 million, primarily driven by its CT053 autologous BCMA CAR-T cell therapy. The company also reported a significant 87.7% narrowing of its net loss to RMB 97.861 million.</p><p>Additionally, CARSGEN-B was officially included in the Hong Kong Stock Connect scheme, which is expected to provide mainland investors with more convenient access to the stock. Market analysts view this inclusion as recognition of the company's core CAR-T business development potential and operational compliance, which should enhance market attention and liquidity for the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1106814148","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106814148","pubTimestamp":1773109870,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.The sharp rise follows the company's release of strong annual results, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"个股赛道|科济源-B盘中大涨11.71%业绩强劲且纳入沪股通","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.The sharp rise follows the company's release of strong annual results, which showed revenue jumping 218.7% year-on-year to RMB 126 million, primarily driven by its CT053 autologous BCMA CAR-T cell therapy. The company also reported a significant 87.7% narrowing of its net loss to RMB 97.861 million.Additionally, CARSGEN-B was officially included in the Hong Kong Stock Connect scheme, which is expected to provide mainland investors with more convenient access to the stock. Market analysts view this inclusion as recognition of the company's core CAR-T business development potential and operational compliance, which should enhance market attention and liquidity for the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106814148","isCrawlerRequest":true}